Recently, Jafari et al. used the anti-MUC1 Apt to target chitosan NPs containing Docetaxel and insulin-like growth factor receptor 1(IGF-1R) Silencer siRNA (gene silencing by small interfering RNA) to SKBR3 breast cancer cells [87]. The gene discussed is IGF1R; the disease is breast carcinoma.